WebApr 7, 2024 · Curis, Inc.’s trailing 12-month revenue is $10.2 million with a -557.7% profit margin. Year-over-year quarterly sales growth most recently was -6.5%. Analysts expect adjusted earnings to reach $-0.408 per share for the current fiscal year. Curis, Inc. does not currently pay a dividend. WebApr 13, 2024 · Curis Inc. (NASDAQ:CRIS) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 9.26% to the previous day’s close as strong demand from buyers drove the stock to $0.83. Actively observing the price movement in the last trading, the stock closed the session at $0.76, falling within a range of $0.73 and $0.849.

Curis Inc (CRIS) Stock Price Today, News, Quotes, FAQs …

WebGet Curis Inc (CRIS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebApr 13, 2024 · Curis Inc. (NASDAQ:CRIS) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 9.26% to the previous day’s close as strong demand from … flightaides.com

Curis, Inc. (CRIS) Stock Price, News, Quote & History - Yahoo Finance

WebMar 13, 2024 · All news about CURIS, INC. 04/06: Curis Reports Inducement Grants under NASDAQ Listing Rule 5635(4) AQ. 04/05: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR. 04/03: Curis to Present at Upcoming Healthcare Conferences in April: PR. 03/13: Transcript : Curis, Inc., Q4 2024 Earnings Call, Mar 13, … WebCuris, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA … WebMar 2, 2024 · Get the latest news and real-time alerts from Curis, Inc. (CRIS) stock at Seeking Alpha. Curis, Inc. (CRIS) Latest Stock News Seeking Alpha Seeking Alpha … chemical formula of zinc ii phosphate